Viewing StudyNCT00489658

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-05 @ 5:35 PM
Last Modification Date: 2024-10-26 @ 9:33 AM
Study NCT ID: NCT00489658
Status: TERMINATED
Last Update Posted: 2007-06-21
First Post: 2007-06-20
Brief Title: Eflornithine Nifurtimox Late-Stage Human African Trypanosomiasis HATin West Nile Uganda
Sponsor: Epicentre
Organization: Epicentre
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Trypanosomiasis African
Keywords:
Name View
Human African trypanosomiasis View
sleeping sickness View
Trypanosoma brucei gambiense View
combination View
eflornithine View
nifurtimox View
Human African trypanosomiasis sleeping sickness due to Trypanosoma brucei gambiense in the late stage stage 2 or meningo-encephalitic View